Literature DB >> 10919952

Is there a metabolic basis for dietary supplementation?

S H Zeisel1.   

Abstract

To be efficacious, dietary supplements must either provide a nutrient that is normally undersupplied to cells or exert a pharmacologic effect on cellular processes. In the first case, optimal function is achieved when a nutrient required by the organism reaches a specific concentration within the cell. A supplement has benefit only when the normal intake of a bioavailable form of a nutrient is lower than the amount that would provide maximum benefit as judged from all biological perspectives. Metabolic, environmental, and genetic factors can make individual nutrient requirements differ from the estimated needs calculated from population-based data. For example, under certain circumstances intracellular antioxidants may be depleted and a dietary supplement might restore optimal antioxidant protection. In the second case, the dietary supplement contains a constituent that is normally not required by the cell, but this substance is capable of altering normal cell function. For example, herbal preparations may contain ephedrine (a drug), which might alter heart rate so that the amount of blood pumped by the heart is enhanced. An understanding of how the variation in nutrient requirements comes about and of the pharmacologic actions of nutrient supplements can help to identify which individuals are most likely to benefit from dietary supplements.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919952     DOI: 10.1093/ajcn/72.2.507S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  2 in total

1.  Continuing education module-maternal calcium intake and metabolism during pregnancy and lactation.

Authors:  Julie Heringhausen; Kristen S Montgomery
Journal:  J Perinat Educ       Date:  2005

2.  A cross-sectional survey on dietary supplements consumption among Italian teen-agers.

Authors:  Valeria del Balzo; Valeria Vitiello; Alessia Germani; Lorenzo M Donini; Eleonora Poggiogalle; Alessandro Pinto
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.